Ontario Bioscience Industry Organization

What Ontario Bioscience Industry Organization does

OBIO (Ontario Bioscience Innovation Organization) is a not-for-profit, membership-based industry organization founded in 2009 and headquartered at the MaRS Centre in Toronto, Ontario. It supports early-stage and venture-backed life sciences and health technology companies by addressing four core barriers to commercialization: capital access, industry-ready talent, health system adoption, and infrastructure. The organization operates a portfolio of programs including its flagship Early Adopter Health Network (EAHN), which matches commercial-ready Canadian health technologies with 60+ healthcare organizations across Canada for real-world clinical evaluation with funding up to $250,000 per project. Complementary programs include the WiHI Seed Program and WeSEED Program (women-led companies, operated jointly with FACIT), the Entrepreneurship Training Program for Women in STEM, and the annual OBIO Investment Summit. Revenue is generated through annual non-refundable membership fees across multiple tiers (early-stage companies, investors, pharma/medtech, academic/government, service providers, umbrella members) supplemented by government program grants, anchored by a $6.2 million FedDev Ontario investment.

OBIO's customer base spans early-stage companies, healthcare providers, investors, academic institutions, and government agencies. Its flagship EAHN network has evaluated 70+ applications since 2020 and engaged 200+ health technology companies, producing documented outcomes including catalyzed financing rounds for participants (e.g., Flosonics Medical) and subsequent procurement by healthcare organizations (e.g., Bruyère procuring Able Innovations' patient transfer system). The organization maintains 11+ innovation organization partnerships across Canada and has expanded its mandate in 2025-2026 to include critical technologies, defence and dual-use applications, and AgeTech. Leadership transitioned to Dr. Maura Campbell as President and CEO, with a stated focus on domestic commercialization, IP retention, and health sovereignty.

Name

Ontario Bioscience Industry Organization

Legal name

Ontario Bioscience Innovation Organization

Website

https://obio.ca

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Toronto

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others, Infrastructure

Revenue model

1. Membership Fees: OBIO charges annual membership fees for organizations including early-stage companies, investors, academic/government/not-for-profit organizations, commercial pharma and medtech companies, umbrella members, and service providers. Membership fees are non-refundable and valid for one calendar year.
2. Government Funding and Program Grants: OBIO receives government funding to support its programs including EAHN, capital access initiatives, and skills development programs. Programs such as EAHN provide funding up to $250,000 per project for technology evaluations.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

Core offering

OBIO is a not-for-profit, membership-based industry organization that supports early-stage and venture-backed life sciences and health tech companies through programs including membership access, the Early Adopter Health Network (EAHN) for technology evaluation with healthcare organizations, the Women in Health Initiative (WiHI), skills development and training courses, capital access programs, and an annual Investment Summit. It does not develop its own technology products; its core offering is ecosystem coordination, networking, mentorship, advocacy, and program management for the Ontario and Canadian health technology innovation sector.

Product overview

OBIO (Ontario Bioscience Innovation Organization) is a not-for-profit, membership-based organization founded in 2009 that supports early-stage and venture-backed life sciences and health tech companies. Rather than a unified software product, OBIO offers a portfolio of programs and services including: membership access to mentorship and expert resources; the Early Adopter Health Network (EAHN) which evaluates health technologies with healthcare organizations; the WiHI Seed Program and WeSEED Program for women-led companies; skills development and training initiatives; and the annual OBIO Investment Summit. These programs collectively help companies raise capital, train talent, commercialize technologies, and access healthcare infrastructure.

Differentiator

Problem solved

Functional benefit

Brands

• Early Adopter Health Network (EAHN): A network of health organizations that evaluates, disseminates and procures leading-edge health technologies. The program matches Canadian health technology companies with healthcare organizations for real-world technology evaluation.

Products and services

• OBIO Membership Annual membership program providing companies and their teams access to mentorship, expert resources, grants, and experiential learning opportunities. Health science partners can join to network, access events, and connect with member companies. Available tiers include early-stage companies, investors, academic/government/not-for-profit, commercial pharma/medtech, umbrella members (accelerators/incubators), and service providers.
• Early Adopter Health Network (EAHN) A national program that matches Canadian health technology companies with healthcare organizations to evaluate technologies in real-world clinical settings, providing up to $250,000 per project in funding. The network spans 60+ healthcare organizations across Canada from Western to Eastern provinces, including hospitals, long-term care facilities, and primary care organizations. EAHN supports both technology evaluation and procurement pathways.
• WiHI Seed Program Investment program supporting women-led companies in life sciences and health tech. Provides direct seed investments to portfolio companies, with Block Biosciences receiving a $100,000 investment through this program during OBIO's International Women's Month celebration.
• WeSEED Program Joint program with FACIT investing in women-led oncology companies, with women-led companies representing over 40% of the portfolio. Designed to address historical underfunding of women-led companies in the oncology and life sciences sector.
• Entrepreneurship Training Program for Women in STEM Training program launched in March 2026 in partnership with University of Toronto's PRiME initiative and BioLabs - University of Toronto to support 25-30 female innovators annually in life sciences and health tech entrepreneurship.
• Life Sciences Central
• Skills Development and Training Programs Programs focused on hiring and training industry-ready talent for life sciences and health tech companies, including the Health Science Industry Training Course, Cybersecurity & Digital Health Training, and the ENGAGE Entrepreneurship Learning Pathway.
• Capital Access and Adoption Programs Programs helping early-stage and venture-backed companies raise capital and facilitate commercialization and market adoption of their technologies, including connections to investors and policy advocacy.
• OBIO Investment Summit Annual investment summit bringing together life sciences and health tech companies, investors, and ecosystem partners for networking, deal flow visibility, and partnership opportunities.
• Future Female Leaders in Life Sciences Program Program launched in October 2025 by OBIO to develop future female leaders in life sciences, complementing its broader Women in Health Initiative (WiHI) suite of programs.

Quantifiable outcome

• Companies participating in EAHN have attracted subsequent financing - Joe Eibl, CEO of Flosonics Medical stated 'Our participation in the EAHN was a catalyzing event for our recent financing round.'
• +3 more outcomes

Named customers23 records

Segments9 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

105 partnerships are on record, tiered core, flagship and minor.

• A4icoreTechnology or Integration · 12 June 2026OBIO supported A4i to expand Canadian presence through partnership with Waypoint Centre for Mental Health Care for patient populations with severe mental illness.
• McGill University Health Centre (MUHC)coreImplementation/ SI/ Consulting Partner · 12 May 2026Through OBIO's EAHN, MUHC partnered in May 2026 to evaluate CareChain, enabling advanced musculoskeletal surgical assessment and triage.
• ventureLABcoreStrategic or Co-development Partner · 9 April 2026ventureLAB and OBIO signed a Memorandum of Understanding (MOU) in April 2026 to help Ontario healthtech companies diversify their global market presence.
• University of Toronto (PRiME Initiative)coreStrategic or Co-development Partner · 31 March 2026OBIO partnered with University of Toronto's PRiME initiative and BioLabs - University of Toronto to launch the Entrepreneurship Training Program for Women in STEM in March 2026. The program supports 25-30 female innovators annually.
• BioLabs - University of TorontocoreStrategic or Co-development Partner · 31 March 2026OBIO partnered with BioLabs - University of Toronto and University of Toronto's PRiME initiative to deliver the Entrepreneurship Training Program for Women in STEM, launching March 2026.
• Esprit-aicoreTechnology or Integration · 11 March 2026Esprit-ai partnered with Perley Health and OBIO to advance dementia care in long-term care homes through EAHN.
• Mohawk MedbuycoreStrategic or Co-development Partner · 9 December 2025OBIO and Mohawk Medbuy formed a partnership in December 2025 to advance healthcare innovation in Canada through collaborative procurement and adoption initiatives.
• St. Joseph's Healthcare HamiltoncoreTechnology or Integration · 4 November 2025St. Joseph's Healthcare Hamilton implemented made-in-Canada technology for real-time equipment tracking and improved patient experience through EAHN.
• KA ImagingcoreTechnology or Integration · 30 October 2025KA Imaging developed Reveal™ Mobi Pro mobile X-ray technology adopted by UHN with support from OBIO's programs and government agencies. OBIO's EAHN facilitated earlier technology evaluations for KA Imaging.
• The Ottawa HospitalcoreTechnology or Integration · 29 October 2025OBIO drove AI innovation in critical care with The Ottawa Hospital's use of Extubation Advisor through EAHN.
• MaRSflagshipStrategic or Co-development Partner · 27 October 2025MaRS, OBIO, and TIAP jointly launched Life Sciences Central in October 2025, a new initiative to facilitate growth and commercialization of healthcare startups in Ontario. The initiative addresses historical fragmentation in the ecosystem, attracts investment, and positions Ontario as a leading global hub for health innovation.
• TIAP (Toronto Institute for Pharmaceutical Technology)flagshipStrategic or Co-development Partner · 27 October 2025TIAP partnered with MaRS and OBIO to launch Life Sciences Central in October 2025, aiming to strengthen Canada's commercialization engine for health innovations.
• Supply OntariocoreStrategic or Co-development Partner · 2 October 2025Supply Ontario and OBIO partnered in October 2025 to drive procurement of Canadian-made innovative healthcare solutions, building on Ontario's new Health Innovation Pathway.
• Health EspressocoreTechnology or Integration · 3 September 2025Durham Ontario Health Team and Community Care Durham partnered with Health Espresso through EAHN with OBIO support to launch innovative community engagement tool.
• GotcarecoreTechnology or Integration · 13 August 2025Campbellford Memorial Hospital's new homecare program partnered with Gotcare through EAHN, freeing up 14.5 hospital bed-days per patient.
• 16 BitcoreTechnology or Integration · 29 July 202516 Bit initiated evaluation of AI-based opportunistic osteoporosis screening using routine X-rays at UHN through EAHN.
• Intellectual Property Ontario (IPON)coreStrategic or Co-development Partner · 14 May 2025OBIO and IPON renewed their multi-year collaboration in May 2026 to advance Ontario's sovereign IP capacity, helping companies protect and commercialize their intellectual property.
• MEDTEQ+coreStrategic or Co-development Partner · 6 May 2025MEDTEQ+ and OBIO partnered in May 2025 to accelerate the development of AgeTech innovations across Canada. Both are not-for-profit organizations offering programs to support health technology commercialization.
• Trexo RoboticscoreTechnology or Integration · 15 January 2025OBIO supported Trexo Robotics to help young patients walk at McMaster Children's Hospital through EAHN partnership with Hamilton Health Sciences.
• peopleCarecoreTechnology or Integration · 27 November 2024peopleCare partnered with OBIO to assess Ontario-made AI-based wound management solution in long-term care settings through EAHN.
• trevii (Technology Trace Inc.)coreTechnology or Integration · 26 September 2024OBIO and St. Joseph's Healthcare Hamilton partnered to evaluate trevii data analytics platform for medical assets management to improve patient flow.
• Synaptive MedicalcoreTechnology or Integration · 27 August 2024Synaptive Medical partnered with Unity Health Toronto through EAHN to test new software for brain surgery planning.
• Vena MedicalcoreTechnology or Integration · 10 July 2024The Ottawa Hospital was first to adopt Vena Medical's innovative stroke treatment device through EAHN, a significant advancement in stroke care.
• 16 Bit Inc.coreTechnology or Integration · 4 July 202416 Bit developed AI-powered screening tool for osteoporosis evaluation at Canada's largest research hospital (UHN) through EAHN.
• Esprit-aicoreTechnology or Integration · 27 June 2024Esprit-ai, Perley Health and OBIO partnered on groundbreaking dementia care project in long-term care homes to support high quality care.
• BayercoreTechnology or Integration · 25 June 2024Bayer partnered with Luxsonic and OBIO for enhanced use of Virtual Imaging Platform in clinical trials, supported by OBIO.
• MEMOTEXTcoreTechnology or Integration · 13 June 2024MEMOTEXT, CAMH and OBIO partnered to support healthcare workers' mental health through digital engagement.
• GotcarecoreTechnology or Integration · 11 June 2024Gotcare's program evaluation at Women's College Hospital improved healthcare accessibility for homebound older adults through EAHN.
• TeleVUcoreTechnology or Integration · 22 May 2024Humber River Health partnered with TeleVU and OBIO's EAHN to support revolutionary cardiac monitoring platform.
• Mobio InteractivecoreTechnology or Integration · 16 May 2024Mobio Interactive's mobile health platform showed positive potential to support youth mental health, evaluated through EAHN.
• VoycecoreTechnology or Integration · 23 April 2024Voyce, Hamilton Health Sciences and OBIO showcased breakthrough in patient care through language access technology.
• PolyUnitycoreTechnology or Integration · 11 April 2024CHEO selected PolyUnity for 3D printing solution following successful evaluation through EAHN.
• Trexo RoboticscoreTechnology or Integration · 26 March 2024Through OBIO's EAHN, Trexo Plus Robotic Walker enabled children with physical disabilities to achieve personalized rehabilitation.
• ToeFX Inc.coreTechnology or Integration · 5 March 2024Ontario-based ToeFX Inc. treated toenail fungal infections effectively for seniors through EAHN support.
• RostrumcoreTechnology or Integration · 31 January 2024Rostrum, Southlake and OBIO evaluated non-invasive real-time bedside monitoring system for mechanically ventilated patients in ICU.
• PhyxablecoreTechnology or Integration · 19 December 2023Phyxable partnered with Right at Home and OBIO to revolutionize senior healthcare with falls prevention program.
• Gray Oncology SolutionscoreTechnology or Integration · 28 November 2023The Ottawa Hospital, OBIO and Gray Oncology Solutions partnered to improve access to cancer care through innovative technology.
• Zamplo Inc.coreTechnology or Integration · 22 November 2023University Health Network partnered with Zamplo Inc. through EAHN to optimize technology-enabled cancer remote monitoring.
• Frontier Medical DevicescoreTechnology or Integration · 7 November 2023Made-in-Ontario medical device proven to save lives was being evaluated in its home province through EAHN.
• A4i (App4Independence)coreTechnology or Integration · 19 October 2023A4i and The Royal Ottawa Mental Health Centre awarded funding from EAHN to evaluate digital app-based platform for severe mental illness.
• A.I. VALIcoreTechnology or Integration · 12 October 2023Centre Hospitalier de l'Université de Montréal (CHUM) partnered with A.I. VALI through EAHN to evaluate AI platform for real-time endoscopy image analysis.
• HypercarecoreTechnology or Integration · 19 September 2023Hypercare helped cut pagers and paper on-call schedules at Southlake through OBIO's support.
• Huron Digital PathologycoreTechnology or Integration · 13 September 2023EAHN supported evaluation of Huron Digital Pathology's technology solutions for faster and more accurate diagnoses at Grand River Hospital.
• PolyUnitycoreTechnology or Integration · 12 July 2023CHEO successfully evaluated in-house 3D printing as a solution to save time and money through EAHN.
• Manage My PaincoreTechnology or Integration · 5 July 2023New study setting the stage for non-opioid analgesic in post-surgical pain management through EAHN.
• TBDcoreTechnology or Integration · 29 June 2023Making managing asthma easier for patients and providers through EAHN evaluation.
• Mobio InteractivecoreTechnology or Integration · 1 June 2023CHEO Research Institute study examined feasibility and engagement with Mobio Interactive mobile mindfulness therapy for youth.
• GotcarecoreTechnology or Integration · 23 May 2023Women's College Hospital evaluated Gotcare to enhance care journey for homebound older adults through EAHN.
• Toch SleepsensecoreTechnology or Integration · 2 May 2023Toch Sleepsense technology enabled retirement home staff to monitor overnight bed-exits for seniors with real-time alerts.
• ToeFX Inc.coreTechnology or Integration · 11 April 2023Innovative project treated toenail fungal infections easily and effectively for seniors through EAHN.
• CommunitechcoreStrategic or Co-development Partner · 6 April 2023OBIO and Communitech partnered in April 2023 to facilitate adoption of made-in-Canada healthcare solutions through shared commitment to supporting the health technology innovation ecosystem.
• Trexo RoboticscoreTechnology or Integration · 4 April 2023OBIO enabled Alberta Health Services to partner with Trexo Robotics to evaluate Robotic Walking Device for Children's Rehabilitation.
• MEMOTEXTcoreTechnology or Integration · 30 March 2023Innovative digital device supports healthcare workers' mental health through EAHN evaluation.
• ManagingLifecoreTechnology or Integration · 27 March 2023ManagingLife's Manage My Pain app partnered with Alberta Health Services for chronic pain treatment through EAHN.
• Able InnovationscoreTechnology or Integration · 27 February 2023Bruyère procured innovative patient transfer technology by Able Innovations following successful EAHN evaluation.
• Voyce CanadacoreTechnology or Integration · 23 February 2023Hamilton Health Sciences and Voyce Canada evaluated video remote medical interpretation services through EAHN.
• TBDcoreTechnology or Integration · 6 February 2023Revolutionary surgery closure device evaluated at Alberta Health Services through EAHN.
• MEMOTEXT Corp.coreTechnology or Integration · 26 January 2023MEMOTEXT and CAMH awarded funding from EAHN to trial automated mental health texting check-in, support and navigation tool.
• TBDcoreTechnology or Integration · 24 January 2023Kingston Health Sciences Centre ensured the beat goes on with virtual cardiac monitoring through EAHN.
• Gray Oncology SolutionscoreTechnology or Integration · 12 January 2023The Ottawa Hospital and Princess Margaret Cancer Centre partnered with Gray Oncology Solutions to tackle operational challenges in radiation oncology.
• TAMVOES HealthcoreTechnology or Integration · 18 November 2022Grand River Hospital partnered with TAMVOES Health to empower patients during their healthcare journey.
• Sunnybrook Health Sciences CentrecoreTechnology or Integration · 7 November 2022Sunnybrook piloted bioelectronic platform for peripheral nerve repair and regeneration through EAHN partnership, bringing decades of nerve science into the operating room.
• Oncoustics AIcoreTechnology or Integration · 14 September 2022Oncoustics AI and UHN awarded EAHN grant to trial point of care liver assessment solutions in clinic.
• Goji Technology SystemscoreTechnology or Integration · 9 June 2022EAHN and City of Kawartha Lakes Family Health Team launched project with Goji Voice AI platform to improve patient experience through EAHN.
• EAHN Healthcare Members NetworkflagshipStrategic or Co-development Partner · 29 September 2021EAHN network includes 18+ healthcare organizations including Baycrest, Bruyère, CAMH, Hamilton Health Sciences, Health Sciences North, Hôtel-Dieu Grace, Joseph Brant Hospital, Kingston Health Sciences Centre, Michael Garron Hospital, North York General Hospital, Southlake Regional Health Centre, St. Mary's General Hospital, The Ottawa Hospital, Unity Health Toronto, UHN, West Park Healthcare Centre, Winchester District Memorial Hospital, Women's College Hospital, and expanded to include Alberta Health Services, Providence Health Care, CHEO, and many others.
• EAHN Innovation Organization PartnersflagshipStrategic or Co-development Partner · 29 September 2021EAHN works with 11+ innovation organization partners including Carleton University, Clinical Trials Ontario, Invest Ottawa, Life Sciences British Columbia, Montréal InVivo, Ontario Institute for Regenerative Medicine, Ryerson Biomedical Zone, SOSCIP Consortium, StarFish Medical, Stem Cell Network, and Synapse Life Science Consortium.
• Carleton UniversitycoreStrategic or Co-development Partner · 29 September 2021Carleton University is an EAHN innovation organization partner, supporting the network with research and academic resources.
• Clinical Trials OntariocoreStrategic or Co-development Partner · 29 September 2021Clinical Trials Ontario is an EAHN innovation organization partner providing support for clinical trial coordination.
• Invest OttawacoreStrategic or Co-development Partner · 29 September 2021Invest Ottawa is an EAHN innovation organization partner supporting Ottawa-based companies.
• Life Sciences British ColumbiacoreStrategic or Co-development Partner · 29 September 2021Life Sciences British Columbia is an EAHN innovation organization partner extending network to Western Canada.
• Montréal InVivocoreStrategic or Co-development Partner · 29 September 2021Montréal InVivo is an EAHN innovation organization partner extending network to Quebec.
• Ontario Institute for Regenerative MedicinecoreStrategic or Co-development Partner · 29 September 2021Ontario Institute for Regenerative Medicine is an EAHN innovation organization partner supporting regenerative medicine companies.
• Ryerson Biomedical ZonecoreStrategic or Co-development Partner · 29 September 2021Ryerson Biomedical Zone is an EAHN innovation organization partner supporting biomedical startups in Toronto.
• SOSCIP ConsortiumcoreStrategic or Co-development Partner · 29 September 2021SOSCIP Consortium is an EAHN innovation organization partner providing advanced computing resources for health research.
• StarFish MedicalcoreStrategic or Co-development Partner · 29 September 2021StarFish Medical is an EAHN innovation organization partner providing medical device design and manufacturing expertise.
• Stem Cell NetworkcoreStrategic or Co-development Partner · 29 September 2021Stem Cell Network is an EAHN innovation organization partner supporting stem cell and regenerative medicine research.
• Synapse Life Science ConsortiumcoreStrategic or Co-development Partner · 29 September 2021Synapse Life Science Consortium is an EAHN innovation organization partner coordinating life sciences ecosystem in Hamilton-Niagara region.
• FACITcoreStrategic or Co-development Partner · 1 January 2021OBIO and FACIT jointly operate the WeSEED program, celebrating its first anniversary in March 2026. The program has invested in women-led oncology companies representing over 40% of its portfolio.
• KA ImagingcoreTechnology or Integration · 1 January 2020KA Imaging's Reveal 35C portable dual energy x-ray device was one of the first eight EAHN projects, evaluated at UHN for COVID-19 screening and improved diagnostic imaging in ICU.
• Synaptive MedicalcoreTechnology or Integration · 1 January 2020Synaptive Medical partnered with UHN through EAHN to test novel MRI drape technology designed to reduce COVID-19 contamination during diagnostic imaging procedures.
• Flosonics MedicalcoreTechnology or Integration · 1 January 2020Flosonics Medical's FloPatch wireless wearable Doppler blood flow device was evaluated with Health Sciences North through EAHN, advancing the technology to market.
• Able InnovationscoreTechnology or Integration · 1 January 2020Able Innovations partnered with Bruyère through EAHN to evaluate the ALTA Platform automated patient transfer system, enabling single-operator patient transfers to reduce staff injuries.
• Therapeutic Monitoring SystemscoreTechnology or Integration · 1 January 2020Therapeutic Monitoring Systems partnered with The Ottawa Hospital through EAHN to evaluate Extubation Advisor, helping physicians determine safe timing for removing patients from ventilation.
• Huron Digital PathologycoreTechnology or Integration · 1 January 2020Huron Digital Pathology partnered with Grand River Hospital through EAHN to evaluate AI-based image search platform for pathologists to increase speed and efficacy of patient care.
• HypercarecoreTechnology or Integration · 1 January 2020Hypercare developed mobile-first digital healthcare collaboration app evaluated through EAHN for continuity of care across hospital, long-term care, community, and family practice settings.
• MaRSflagshipStrategic or Co-development PartnerOBIO, MaRS, and TIAP form the Life Sciences Central partnership, emphasizing the critical role Canada's domestic life sciences sector plays in defense and commercialization of homegrown health technologies.
• TIAPflagshipStrategic or Co-development PartnerOBIO, MaRS, and TIAP form the Life Sciences Central partnership, collaborating to unlock Canada's full economic and innovation potential in health technologies.
• Alberta Health ServicescoreTechnology or IntegrationAlberta Health Services is a healthcare organization member of EAHN network, providing services to over 4.4 million people in Alberta.
• Providence Health CarecoreTechnology or IntegrationProvidence Health Care is an EAHN member healthcare organization operating 17 sites in British Columbia.
• CHEOcoreTechnology or IntegrationCHEO is a globally recognized leader in pediatric healthcare and research, EAHN member evaluating 3D printing and other innovations.
• Sunnybrook Health Sciences CentrecoreTechnology or IntegrationSunnybrook is one of Canada's largest academic health sciences centres, treating 1.3 million patients annually, EAHN member.
• Unity Health TorontocoreTechnology or IntegrationUnity Health Toronto (Providence Healthcare, St. Joseph's Health Centre, St. Michael's Hospital) is an EAHN member.
• University Health NetworkcoreTechnology or IntegrationUHN is Canada's largest research hospital network (Toronto General, Toronto Western, Princess Margaret, etc.), EAHN member evaluating multiple technologies.
• The Ottawa HospitalcoreTechnology or IntegrationThe Ottawa Hospital serves 1.2 million people in Eastern Ontario, EAHN member first to adopt innovative stroke treatment technology.
• Centre Hospitalier de l'Université de Montréal (CHUM)coreTechnology or IntegrationCHUM is a major Quebec healthcare institution, EAHN member evaluating AI for endoscopy image analysis.
• McGill University Health Centre (MUHC)coreTechnology or IntegrationMUHC is one of the most modern and largest university health networks in North America, EAHN member evaluating CareChain.
• BioAlbertaminorStrategic or Co-development PartnerBioAlberta is a Western Canada ecosystem partner of EAHN representing Alberta's life sciences sector.
• Edmonton GlobalminorStrategic or Co-development PartnerEdmonton Global is a Western Canada ecosystem partner of EAHN supporting global health connections.
• Health CitiesminorStrategic or Co-development PartnerHealth Cities is a Western Canada ecosystem partner of EAHN supporting health innovation in Alberta.
• Life Sciences BCminorStrategic or Co-development PartnerLife Sciences BC is a Western Canada ecosystem partner of EAHN representing British Columbia's life sciences industry.
• Deep Tech CanadaminorStrategic or Co-development PartnerDeep Tech Canada is a Western Canada ecosystem partner of EAHN supporting deep technology innovation.
• Starfish MedicalcoreStrategic or Co-development PartnerStarfish Medical is a Western Canada ecosystem partner of EAHN providing medical device design services.
• Thin Air LabsminorStrategic or Co-development PartnerThin Air Labs is a Western Canada ecosystem partner of EAHN supporting digital health innovation.
• CQIB (Centre for Quantitative Medicine)minorStrategic or Co-development PartnerCQIB is an Eastern Canada ecosystem partner of EAHN from Quebec supporting quantitative health research.
• Montreal InVivocoreStrategic or Co-development PartnerMontreal InVivo is an Eastern Canada ecosystem partner of EAHN representing Montreal's life sciences cluster.

Scale indicators9 records

Recent moves6 records

Expansion highlights7 records

Direct peers

• Communitech: Ontario/Waterloo-region innovation hub supporting tech startups including healthtech. Comparable to OBIO through shared Ontario-based startup commercialization focus; partnership since April 2023.
• MEDTEQ+: Canadian medical technologies consortium accelerating innovation from research to market. Comparable to OBIO through shared focus on health tech commercialization, adoption, and ecosystem partnerships; partnered with OBIO on AgeTech in 2025.
• ventureLAB: Ontario-based innovation hub supporting hardware, healthtech, and AI startups with commercialization programs. Comparable to OBIO's mission of supporting Ontario tech commercialization; MOU partner since April 2026.
• BioAlberta: Alberta's life sciences industry association providing networking, advocacy, and commercialization support. Direct comparable to OBIO with similar membership and ecosystem-building mission; partnered with OBIO on EAHN.
• Montréal InVivo: Québec's life sciences and health technologies cluster organization. Direct comparable to OBIO as a Canadian provincial industry association focused on life sciences commercialization and ecosystem coordination; EAHN innovation partner.
• Life Sciences British Columbia: BC's life sciences industry association supporting commercialization, investment, and ecosystem development. Direct comparable to OBIO as a Canadian provincial life sciences membership organization; already an EAHN innovation organization partner.
• Health Cities: Alberta-based not-for-profit supporting health innovation and commercialization through industry partnerships. Comparable to OBIO in mission and approach; EAHN Western Canada ecosystem partner.
• FACIT: Ontario-focused commercialization accelerator for oncology innovations, operating the WeSEED program jointly with OBIO. Closely comparable to OBIO through shared mission of advancing Ontario healthtech commercialization, particularly women-led companies.

Broad incumbents

• BIOTECanada: National industry association for Canada's biotechnology sector, with broader scope across all biotech subsectors. Comparable to OBIO as a national life sciences industry association, though OBIO is more Ontario-focused and health-tech specific.
• MaRS Discovery District: Toronto-based innovation hub supporting health, cleantech, and fintech startups with broader scope than OBIO. Comparable as flagship partner of Life Sciences Central; not a direct industry association peer but a strategic ecosystem partner.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/obioscience
• LinkedInlinkedin.com/company/obioscience

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments5 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ontario Bioscience Industry Organization